AU2001295991A1 - Compositions for improving lipids in blood - Google Patents

Compositions for improving lipids in blood

Info

Publication number
AU2001295991A1
AU2001295991A1 AU2001295991A AU9599101A AU2001295991A1 AU 2001295991 A1 AU2001295991 A1 AU 2001295991A1 AU 2001295991 A AU2001295991 A AU 2001295991A AU 9599101 A AU9599101 A AU 9599101A AU 2001295991 A1 AU2001295991 A1 AU 2001295991A1
Authority
AU
Australia
Prior art keywords
blood
compositions
lipids
improving
improving lipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295991A
Inventor
Tatsuhito Kondo
Masato Nakayama
Tsuneoki Ohsawa
Ippei Shimizu
Ikuo Takagi
Yasuhiro Torizumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU2001295991A1 publication Critical patent/AU2001295991A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2001295991A 2000-10-23 2001-10-22 Compositions for improving lipids in blood Abandoned AU2001295991A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-322076 2000-10-23
JP2000322076 2000-10-23
JP2000383052 2000-12-18
JP2000-383052 2000-12-18
PCT/JP2001/009257 WO2002034261A1 (en) 2000-10-23 2001-10-22 Compositions for improving lipids in blood

Publications (1)

Publication Number Publication Date
AU2001295991A1 true AU2001295991A1 (en) 2002-05-06

Family

ID=26602555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295991A Abandoned AU2001295991A1 (en) 2000-10-23 2001-10-22 Compositions for improving lipids in blood

Country Status (8)

Country Link
US (1) US20030216357A1 (en)
JP (1) JP2008189684A (en)
CN (1) CN1250212C (en)
AU (1) AU2001295991A1 (en)
CA (1) CA2426218A1 (en)
HK (1) HK1062139A1 (en)
TW (1) TWI275389B (en)
WO (1) WO2002034261A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004012740A1 (en) * 2002-08-02 2004-02-12 Sankyo Company, Limited MEDICINAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR
JP4607436B2 (en) * 2002-08-02 2011-01-05 第一三共株式会社 Pharmaceutical composition containing an HMG-CoA reductase inhibitor
CN100415235C (en) * 2002-08-02 2008-09-03 三共株式会社 Medicinal composition containing an HMG-CoA reductase inhibitor
JP2010520208A (en) * 2007-03-01 2010-06-10 コンコース ヘルス サイエンシーズ エルエルシー Isomers of inositol niacinate and uses thereof
US20130072509A1 (en) * 2011-09-15 2013-03-21 ChromaDex Inc. Pterostilbene and statin combination for treatment of metabolic disease, cardiovascular disease, and inflammation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041611A (en) * 1983-08-17 1985-03-05 Sankyo Co Ltd Blood lipid improving agent
US5662934A (en) * 1993-01-05 1997-09-02 Najarian; Thomas Compositions and methods for lowering cholesterol while maintaining antioxidant levels
CA2251972A1 (en) * 1996-04-17 1997-10-23 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
ES2336492T3 (en) * 1997-07-31 2010-04-13 Abbott Respiratory Llc COMPOSITION THAT INCLUDES AN HMG.COA INHIBITOR AND A NICOTINIC ACID COMPOUND TO TREAT HYPERLIPIDEMIA.
US6245797B1 (en) * 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU4699099A (en) * 1998-06-24 2000-01-10 Merck & Co., Inc. Compositions and methods for treating elevated blood cholesterol
JP4132773B2 (en) * 2000-10-23 2008-08-13 第一三共株式会社 Blood lipid improving agent composition

Also Published As

Publication number Publication date
JP2008189684A (en) 2008-08-21
WO2002034261A1 (en) 2002-05-02
HK1062139A1 (en) 2004-10-21
CA2426218A1 (en) 2003-04-22
TWI275389B (en) 2007-03-11
US20030216357A1 (en) 2003-11-20
CN1481239A (en) 2004-03-10
CN1250212C (en) 2006-04-12

Similar Documents

Publication Publication Date Title
AU2001292993A1 (en) Compositions for reducing side effects in chemotherapeutic treatments
AU2002214324A1 (en) Medicinal compositions
AU2001250443A1 (en) Food composition
AU2001241098A1 (en) Composition
AU2002221131A1 (en) Blood lipid ameliorant composition
AU2001290324A1 (en) Composition for diminishing neutral fat in blood
AU2002210433A1 (en) Dental compositions
AU2002343025A1 (en) Improvements in footwear
AUPQ634300A0 (en) Synergistic formulations
AU2001295991A1 (en) Compositions for improving lipids in blood
AU2001294245A1 (en) Compositions for improving lipid metabolism
AU2001275201A1 (en) Acne-treating composition
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AUPQ644900A0 (en) Preserving compositions
AU2002301358A1 (en) Improvements in Transmissometers
AU2001287852A1 (en) Composition
AU2001235764A1 (en) Compositions
AU2001223721A1 (en) Dental compositions
AU2001287732A1 (en) Copolycarbonate-based composition
AU2002221703A1 (en) Dish-washing compositions
AU2002221130A1 (en) Blood lipid ameliorant composition
AU2001274564A1 (en) Compositions promoting alcohol metabolism
AU2001262163A1 (en) Composition
AU2001284827A1 (en) Virtual showcases
AU2001282541A1 (en) Medicinal compositions